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Questions: Can rules be developed to predict the risk of non-use of prostheses by peoplewith lower limb
amputation following discharge from rehabilitation? Are these clinical prediction rules valid? Design:
Retrospective and prospective cohort study designs. Participants: Consecutive tertiary rehabilitation
patients: 135 retrospective (103 males, mean age = 56 years, SD 15) and 66 prospective (58 males, mean
age = 54 years, SD 16). Method: Medical records were audited for potential predictor variables.
Retrospective participants were interviewed at a median of 1.9 years after discharge (IQR 1.4 to 2.5) and
prospective participants at a median of 1.3 years (IQR 1.1 to 1.4). Results: Clinical prediction rules were
identiﬁed at 4, 8 and 12 months after discharge, and validated. Amputation levels above transtibial and
mobility-aid use were common predictors for all three time frames. At 4 months, if four out of ﬁve
predictor variables were present (LR+ = 43.9, 95% CI 2.73 to 999+), the probability of non-use increased
from 12 to 86% (p < 0.001). At 8 months, if all three predictor variables were present (LR+ = 33.9, 95% CI
2.1 to 999+), the probability of non-use increased from 15 to 86% (p < 0.001). At 12 months, if two out of
three predictor variables were present (LR+ = 2.8, 95% CI 0.9 to 6.6), the probability of non-use increased
from 17 to 36% (p < 0.031). Conclusions: These validated clinical prediction rules have implications for
rehabilitation and service model development. [Roffman CE, Buchanan J, Allison GT (2014) Predictors
of non-use of prostheses by peoplewith lower limb amputation after discharge from rehabilitation:
development and validation of clinical prediction rules. Journal of Physiotherapy 60: 224–231]
Crown Copyright  2014 Published by Elsevier B.V. on behalf of Australian Physiotherapy Association.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).Introduction
Multidisciplinary rehabilitation following lower limb amputa-
tion plays an important role in restoring function for activities of
daily living, work and recreation. Amputee rehabilitation service
models and clinical practice guidelines for prosthetic prescription
varywidely throughout theworld and have been developed largely
from expert consensus.1,2 In Western Australia, patients achieve
independent transfers and wheelchair mobility during inpatient
rehabilitation while prosthetic gait retraining is performed as an
outpatient service.3
Limited research exists on long-term outcomes in relation to
prostheses following discharge from rehabilitation. In particular,
there is a lack of quality evidence to inform clinical decisions that
may impact on the continued use of prostheses following lower
limb amputation.4–9 In their literature review, Sansam et al5 called
for further investigation of predictive factors to more accurately
estimate walking potential because the studies they reviewed
reported different predictors; this was probably due to differences
in methodology, outcome measures and deﬁnitions of prosthetic
rehabilitation success.http://dx.doi.org/10.1016/j.jphys.2014.09.003
1836-9553/Crown Copyright  2014 Published by Elsevier B.V. on behalf of Australian
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Some studies have quantiﬁed prosthetic rehabilitation success
relative to surgery-related outcomes, the duration that the
prosthesis is worn as opposed to functional use, or short-term
outcomes while individuals were still participating in rehabilita-
tion; other studies have limited their analyses to cohorts with
limited rehabilitation potential.8–11 None of these quantify long-
term functional prosthetic use following discharge, which is
important in understanding the quality of life of these people. In
general, for those with atraumatic causes of amputation there is a
decline in health status following discharge and 5-year mortality
as high as 77%.9,12–14 In some cases, prosthetic gait may impair
health and wellbeing through associated morbidity (eg, falls,
myocardial infarction) and many individuals stop using their
prosthesis within 12 months of discharge.12,15
Factors associated with prosthetic outcome have been consid-
ered in univariate analyses. Pre-operative factors such as comorbid-
ities, age, pre-morbid mobility, medications, skin integrity,
ethnicity, socioeconomic status, cognition and social support have
been reported as being associated with outcome.5,6,11,15–18 Weak
evidence supports an association between psychological factors,
self-efﬁcacy,motivation and outcome.5 Prosthetic outcome has alsoPhysiotherapy Association. This is an open access article under the CC BY-NC-ND
Research 225been associated with postoperative factors including high-level or
multiple limb amputation, postoperative complications, wound
healing, oedema, contractures, pain, delay toprosthesis, falls, energy
cost of gait, and functional factors.5,6,9,19–26
Prosthetic outcome is therefore multifactorial and complex. To
date, no studies have examined the factors that in combination are
able to identify individuals at risk of prosthetic non-use following
discharge from rehabilitation. A methodological approach of
developing clinical prediction rules has been used in similar
prognostic studies (eg, ankle fractures, neck pain)27,28 and is yet to
be established in the area of lower limb amputation. Clinical
prediction rules are tools that assist clinicians to make evidence-
based decisions and assign patients to interventions and targeted
models of care using a parsimonious subset of predictor
variables.27–30 If clinical prediction rules could be generated to
accurately identify individuals at risk of early prosthetic non-use,
then rehabilitation teams could intervene with targeted models of
care and prosthetic innovations to optimise functional outcome
and allocation of healthcare resources. Therefore the research
questions for this study were:1. Can rules be developed to predict the risk of non-use of
prostheses by people with lower limb amputation following
discharge from rehabilitation?2. Are these clinical prediction rules valid?
Methods
Participants
Inclusion criteria were: at least one recent major lower limb
amputation (ie, transtibial level or above); community dwelling
and ambulant prior to amputation; Medicare Functional Classiﬁ-
cation K-level 1 to 4 (from Gailey et al24); and had participated in
and been discharged from prosthetic rehabilitation at Royal Perth
Hospital, which is the state centre for amputee rehabilitation.
Royal Perth Hospital rehabilitates 85% of all individuals with lower
limb amputation in Western Australia.3 Individuals with multiple
limb amputations were included, as this was important for validity
of the clinical prediction rules.
Participants were excluded if they were unable to communi-
cate, did not consent, or were not prosthetic candidates (ie, K-level
0) as assessed collaboratively by the rehabilitation physician and
senior physiotherapist. Reasons for K-level 0 categorisation
included comorbidities, cognitive impairment, high-level amputa-
tion, multiple limb amputation, remaining limb pathology,
increased body weight, mental health issues, poor motivation,
no social support, poor premorbid mobility or falls history. TheseBox 1. Predictor variable domains for prosthetic users and non-user
Intrinsic predictor variables Amputation predictor variab
 gender
 age
 indigenous status
 metropolitan versus country
 accommodation at discharge:
home versus residential care
 medical comorbidities: diabetes
type I or II, peripheral arterial
disease, cardiac condition,
renal failure, stroke, transient
ischaemic attack, lower limb
pathology
 number of medical comorbidities,
including mental health issues
and musculoskeletal pathology
 amputation cause
 amputation level
 bilateral lower limb ampu
 time to second lower limb
amputation
 time from amputation to
prosthetic milestones: cas
fitting and definitive prostparticipants were monitored through amputee outpatient clinic
but remained at K-level 0.
K-level 0 to 4 participants underwent inpatient rehabilitation to
achieve independent transfers, wheelchair mobility and discharge
home. K-level 1 to 4 participants received the standardised
outpatient prosthetic rehabilitation service, as detailed in Appen-
dix 1 (see eAddenda).
An independent research assistant contacted potential parti-
cipants from the Amputee Physiotherapy Service database to
obtain informed verbal consent for the interview. The interview
process involved coordinating telephone interviews with country
physiotherapists on remote community visits, Aboriginal Health
workers, nurses, and the use of telehealth.
Procedure
Clinical prediction rules development
Medical records were audited for potential predictor variables
and this was undertaken blind to the interviews. Box 1 outlines the
predictor variable domains investigated. All potential variables
were dichotomised (eg, amputation cause: atraumatic or traumat-
ic). Receiver Operator Characteristic (ROC) curves were used to
generate a threshold for dichotomous classiﬁcation of continuous
variables (eg, age). This was performedwith an equal weighting for
sensitivity and speciﬁcity. Table 1 in the eAddenda details the
dichotomous variable classiﬁcations.
Medical comorbidities (including mental health issues and
musculoskeletal pathology) were recorded and counted for each
participant. Charlson Comorbidity Index and Combined Age
Charlson Comorbidity Index were calculated from medical comor-
bidities data.31
In the present study, amputation level was classiﬁed as
transtibial or above transtibial. Bilateral lower limb amputation
was deﬁned as having undergone two major lower limb amputa-
tions. Participants were classiﬁed as able to independently perform
the locomotor skill or being dependent (ie, required assistance or
unable to perform). Mobility aids were either used or not used, and
the aid type was not statistically weighted for its level of support.
The operational deﬁnition of a successful prosthetic user was
use of the prosthesis for locomotor activities (eg, transfers,
standing, walking) on one or more week days. Participants were
asked on which days they used their prosthesis and for one day of
normal activity how long they wore the prosthesis, how many sit
to stands they performed, and the duration they performed
prosthetic walking and standing activities.
Prosthetic non-users did not use their prosthesis for locomotor
activities on any days. Individuals who only wore their prosthesis
for cosmesis were classiﬁed as non-users. Non-users were askeds investigated by this study.
les Functional predictor variables
tation
ting,
hesis
 mobility level achieved without a prosthesis:
wheelchair mobility, transfers, hopping
 independence with donning and doffing prosthesis,
and monitoring prosthetic fit at discharge
 mobility aid use at discharge
 mobility level achieved using a prosthesis at
discharge: walking indoors, outdoors, stairs,
slopes, grass, gravel, uneven terrain, high-level
balance activities and running
[(Figure_1)TD$FIG]
Patient details:
Significant predictor variables:
amputation level above transtibial
mobility aid use at discharge
Total number of predictor variables:
dependence walking outdoors on 
concrete at discharge
not having a diagnosis of type II 
diabetes
19 or more comorbidities 
(95th percentile)
delay to prosthesis ≥ 160 days
(95th percentile) 
4 (and 6) 
months
12
months
8
months
Time since discharge
Figure 1. Validated clinical prediction rules for prosthetic non-use in individuals with lower limb amputation at 4, 8 and 12months after discharge from rehabilitation. If the
participant has the predictor variable, they score 1, which is written in the white box, and if they do not have the predictor variable, they score 0. At 4 (and 6) months, scores
total out of 5, and at 8 and 12months, scores total out of 3. Total score (below the line) is used for the risk estimates at each time point. For full details on use, see Appendix 2.
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months after physiotherapy discharge they stopped using their
prosthesis. Important calendar events (eg, last amputee outpatient
clinic, birthday, Christmas) were used as verbal prompts to assist
with recall accuracy. Participants were interviewed with a
previously piloted survey on their prosthetic use from 4 months
onwards after discharge and re-interviewed approximately at 2-
monthly intervals until data were collected for 12 months.
Clinical prediction rules validation
The procedure used for clinical prediction rules validation were
the same as for the development procedure, except that data were
prospectively collected during the participants’ rehabilitation
using a physiotherapy assessment form. This form was developed
and implemented by the senior physiotherapist during clinical
prediction rules development.
Statistical analyses
Clinical prediction rules development
The statistical models used in the present study are consistent
with clinical prediction rules reports27–30 and are not equivalent to
a regression analysis. The primary outcome variablewas prosthetic
non-use at 4, 6, 8 and 12 months post-discharge. Descriptive
statistics were generated.
The univariate relationship between categorical variables and
prosthetic users and non-users was analysed using the chi-square
test. For each of the continuous variables, ROC curves were used to
determine the threshold at which speciﬁcity and sensitivity were
equal to generate dichotomous classiﬁcation for the univariate
analyses. Univariate contingency tables were used to identify a
smaller subset of variables related to prosthetic non-use that had a
signiﬁcance level of 10% (chi-square p < 0.10). This conservative
signiﬁcance level was selected to avoid missing critical variables.
Sensitivity, speciﬁcity, and positive and negative likelihood ratios
were calculated for the variables.
A backwards stepwise logistic regression model was used to
reduce these variables to a set of ﬂags or key variables that
contributed to predicting non-use. To generate clinical predictionrules for the time frames, the set of variables fromthe regressionwas
used to establish cumulative numbers of items present for any one
individual at discharge. A list of likelihood ratios (negative and
positive, 95% CI) were calculated to determine the cumulative effect
of having a number of these predictors (1, 2, 3, etc) on non-use.
Clinical prediction rules validation
Prospective participants were classiﬁed as prosthetic users or
non-users at 4, 6, 8 and 12 months after discharge. Descriptive
statistics were generated. Participants were analysed for the
absence (score = 0) or presence (score = 1) of signiﬁcant clinical
prediction rules variables at 4, 6, 8 and 12 months (see Figure 1,
and the clinical prediction rules instructions in Appendix 2 in the
eAddenda). Validity and cohort contamination effects of prosthetic
use behaviours were compared by plotting pattern of non-use over
time for the retrospective and prospective cohorts.
The retrospective study’s continuous variable thresholds were
used to generate dichotomous classiﬁcation of these continuous
variables in the present prospective study. To validate the clinical
prediction rules for each of the time frames, chi-square tests were
calculated to generate a progressive list of likelihood ratios
(negative and positive, 95% CI) to determine the cumulative effect
of having a number (ie, 1, 2, 3 etc) of these non-use predictors.
Sensitivity, speciﬁcity, positive prediction value, accuracy and
balanced accuracy were calculated to deﬁne the accuracy and
precision of clinical prediction rules in the prospective cohort.32
For both the retrospective and prospective statistical analyses,
in circumstances where zero cases were present in frequency cells
of the 2 x 2 contingency tables, 0.5 was added to the cell values to
enable calculation of the likelihood ratios for the variables.33
Extreme likelihood ratio upper conﬁdence limits were truncated
at 999.
Sensitivity analyses of 29 (16%) retrospective and eight (10%)
prospective deceased prosthetic rehabilitation participants who
could not be interviewedwere performed for 4, 6, 8 and 12months
after discharge to identify the presence or absence of clinical
prediction rules variables using date of death as the termination
date for prosthetic use.
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Table 2 summarises the consecutive participants’ eligibility for
the study. The ﬁnal response rates were 94% (n = 135) for the
retrospective cohort and 97% (n = 66) for the prospective cohort.
The retrospective cohort were interviewed at median = 1.9 years
(IQR 1.4 to 2.5) and prospective at median 1.3 years (IQR 1.1 to 1.4)
after discharge. Table 3 outlines the geographical distribution of
participants, as measured by Accessibility Remoteness Index of
Australia.34
Clinical prediction rules development interviews with the
retrospective cohort were performed by telephone (n = 123),
telehealth (n = 2) and in person (n = 10). Twelve interviews were
performed with carer assistance due to language interpretation,
hearing or intellectual disability. Clinical prediction rules valida-
tion interviews with the prospective cohort were performed by
telephone (n = 47) and in person (n = 19). Carers assisted with two
interviews where participants had a hearing or intellectual
disability. Table 3 shows the retrospective and prospective cohort
characteristics.
Clinical prediction rules development
From November 2009 until August 2011, 135 participants were
interviewed; 94 (70%) were prosthetic users and 41 (30%) were
non-users. At 4, 6, 8 and 12 months after discharge from
rehabilitation 15 (11%), 15 (11%), 20 (15%) and 25 (19%) of
participants, respectively, were non-users. As the number of
prosthetic non-users and variables were identical for 4 and
6 months, these data were analysed as one time frame.
Of the 40 potential variables investigated for the univariate
analysis (Box 1), a total of 16 variables were identiﬁed as being
signiﬁcant (p < 0.10) for prosthetic non-use at the 4-, 6- and 8-
month timeframes, and 15 variables were signiﬁcant at 12 months
after discharge (Table 4, which is available in the eAddenda).
The predictor variables signiﬁcant (95% CI) for prosthetic non-
use after being entered into the backwards-stepwise logistic
regression model are reported below. Full details, including
associated accuracy statistics, are presented in Table 5.
Clinical prediction rules: 4 months
At 4 (and 6) months, the ﬁve variables that were predictive of
prosthetic non-use included: amputation level above transtibial
level, mobility aid use, dependence walking outdoors on concrete,
very high number of comorbidities, and not having a diagnosis of
type II diabetes.
Clinical prediction rules: 8 months
At 8 months, the three variables that were predictive of
prosthetic non-use included: amputation level above transtibialTable 2
Summary of the consecutive retrospective and prospective cohorts.
Characteristic
Time frame identiﬁed from Amputee Physiotherapy Service database
Consecutive tertiary rehabilitation patients identiﬁed from Amputee Physiotherapy S
K-level 0 participantsa, n (%)
K-level 1 to 4 participantsb, n (%)
K-level 0 deceased, n (%)
K-level 1 to 4 deceased, n (%)
Eligible participants, n
Ineligible participants, n
excluded, minor lower limb amputation
excluded, still participating in rehabilitation
did not consent
Participants contacted, n
Unable to be contacted as they had moved interstate or overseas, n
Response rate, n (%)
Time to outpatient discharge (d)c, median (IQR)
a Not prosthetic rehabilitation candidates.
b Prosthetic users at discharge.
c Participants participated in approximately two to three physiotherapy prosthetic glevel, mobility aid use, and dependence walking outdoors on
concrete.
Clinical prediction rules: 12 months
At 12 months, the three variables that were predictive of
prosthetic non-use included: amputation level above transtibial
level, mobility aid use, and delay to prosthesis. The multifactorial
causes of delay to prosthesis included: wound complications
(n = 8), comorbidities (n = 3), orthopaedic injuries (n = 2) and
deconditioning (n = 1).
Clinical prediction rules validation
From March 2011 until December 2012, 66 participants were
interviewed, of whom 55 remained prosthetic users. There were
eight non-users at 4 and 6 months after discharge from
rehabilitation, which increased to ten at 8 months and eleven at
12 months. Similar to the retrospective cohort, prosthetic non-
users and variables were identical for the 4-month and 6-month
timeframes in the prospective cohort.
Survival curves (Figure 2) demonstrated a high level of
concordance between the retrospective and prospective cohorts.
From discharge there was rapid progression to prosthetic non-use,
followed by linear decline after 1 month.
Associated accuracy statistics for having a combination of
prosthetic non-use predictors (95% CI) for the clinical prediction
rules time frames in the prospective cohort are reported below.
Full details, including associated accuracy statistics, are presented
in Table 6.
Four months
If four out of ﬁve predictors were present (LR+ = 43.9, 95% CI
2.73 to 999+), the probability of non-use increased from 12 to 86%
(p < 0.001).
Eight months
If all three predictors were present (LR+ = 33.9, 95% CI 2.1 to
999+), the probability of non-use increased from 15 to 86%
(p < 0.001).
Twelve months
If two out of three predictors were present (LR+ = 2.8, 95% CI
0.9 to 6.6), the probability of non-use increased from 17 to 36%
(p < 0.031). Three cases of delay to prosthesis included: wound (2)
and orthopaedic (1) complications.
Figures 3–5 (available in the eAddenda) illustrate the percen-
tages of true to false positives for the clinical prediction rules time
frames. This shows the clinical utility of using the clinical
prediction rules for any one individual and the risk of appropriate
classiﬁcation.Retrospective cohort Prospective cohort
June 2006 to June 2009 July 2009 to July 2011
ervice database, n 208 99
32 (15) 11 (11)
176 (85) 88 (89)
15 (47) 4 (36)
29 (16) 8 (9)
143 68
1 2
3 10
3 0
138 66
5 2
135 (94) 66 (97)
174 (103 to 314) 138 (88 to 201)
ait retraining sessions per week as outpatients.
Table 3
Demographic and amputation details of prosthetic users and non-users in the retrospective and prospective cohorts.
Demographic and amputation details Retrospective cohort Prospective cohort
Users (n=94) Non-users (n=41) Users (n=55) Non-users (n=11)
Gender, male, n (%) 74 (79) 29 (71) 50 (91) 8 (73)
Age at amputation, mean (SD) 55.1 (15.8) 58.3 (13.3) 55.3 (15.7) 49.5 (19.9)
Indigenous status, Aboriginal, n (%) 12 (13) 9 (22) 6 (11) 2 (18)
Accommodation after discharge from inpatient rehabilitation, n (%)
home 91 (97) 37 (90) 55 (100) 11 (100)
residential care (hostel or nursing home) 3 (3) 4 (10) 0 (0) 0 (0)
metropolitan 56 (60) 28 (68) 34 (62) 9 (82)
country 38 (40) 13 (32) 21 (38) 2 (18)
Social support, lives with others, n (%) 77 (82) 31 (76) 42 (76) 10 (91)
Accessibility Remoteness Index of Australiaa
major cities of Australia (0 to 1.84) 66 (71)a 34 (83) 40 (73) 9 (82)
inner regional Australia (> 1.84 to 3.51) 8 (9) 0 (0) 7 (13) 0 (0)
outer regional Australia (> 3.51 to 5.80) 5 (5) 2 (5) 5 (9) 1 (9)
remote Australia (> 5.80 to 9.08) 0 (0) 2 (5) 2 (4) 0 (0)
very remote Australia (> 9.08 to 12) 14 (15) 3 (7) 1 (2) 1 (9)
Charlson Comorbidity Index, median (IQR) 2 (1 to 4) 5 (2 to 5) 2 (0 to 4) 3 (0.5 to 5)
Combined Age Charlson Comorbidity Index, median (IQR) 4 (1 to 5) 7 (3 to 7) 4 (1 to 6) 6 (1 to 7)
Comorbidities, n (%)
diabetes type I 7 (8) 3 (7) 1 (2) 1 (9)
diabetes type II 35 (37) 19 (46) 21 (38) 6 (55)
peripheral arterial disease 44 (47) 25 (61) 30 (55) 7 (64)
cardiac condition 33 (35) 26 (63) 12 (22) 4 (36)
renal failure 13 (14) 10 (24) 5 (9) 4 (36)
stroke/transient ischaemic attack 8 (9) 5 (12) 4 (7) 0 (0)
arthritis 36 (38) 16 (39) 12 (22) 5 (45)
remaining lower limb pathology 78 (83) 36 (88) 36 (65) 11 (100)
Mental health issues, n (%) 24 (26) 8 (20) 8 (15) 5 (45)
Mild cognitive impairment, n (%) 3 (3) 4 (10) 2 (4) 1 (9)
Intellectual disability, n (%) 1 (1) 0 (0) 1 (2) 0 (0)
Substance abuse, n (%)
drugs 7 (7) 4 (10) 2 (4) 3 (27)
alcohol 10 (11) 5 (12) 7 (13) 2 (18)
current smoker 20 (21) 14 (34) 13 (24) 4 (36)
Amputation cause, n (%)
circulatory 18 (19) 15 (37) 16 (29) 3 (27)
infection 42 (45) 17 (41) 22 (40) 6 (55)
trauma 29 (31) 9 (22) 14 (25) 2 (18)
cancer 5 (5) 0 (0) 3 (5) 0 (0)
Amputation level, n (%)
transtibial 78 (83) 25 (61) 50 (91) 10 (91)
knee disarticulation 4 (4) 2 (5) 1 (2) 0 (0)
transfemoral 20 (21) 28 (68) 9 (16) 5 (45)
major bilateral lower limb amputation 8 (9) 14 (34) 5 (9) 4 (36)
minor amputation of remaining limb 15 (16) 3 (7) 2 (4) 1 (9)
upper limb amputation/s 8 (9) 0 (0) 9 (16) 3 (27)
a n=93. One person was excluded from this retrospective analysis because he moved overseas after discharge. All other retrospective analyses used n=94.
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number of clinical prediction rules variables for the time frames
and cessation of prosthetic use due to death, based on 29 deceased
participants from the retrospective cohort (p = 0.164) and eight
deceased participants from the prospective cohort (p = 0.170).Table 5
Associated accuracy statistics with 95% CI for having a combination of predictor variab
Predictors present for
clinical prediction
rules time frames (n)
Sensitivity Speciﬁcity Po
4 (and 6) months
1
2
3
4
5
0.97 (0.74 to 1.00)
0.97 (0.72 to 1.00)
0.80 (0.53 to 0.95)
0.27 (0.10 to 0.33)
0.03 (0.00 to 0.06)
0.16 (0.13 to 0.16)
0.52 (0.48 to 0.52)
0.75 (0.72 to 0.77)
0.99 (0.97 to 1.00)
0.99 (0.99 to 1.00)
1.2
2.0
3.2
32.
7.8
8 months
1
2
3
0.98 (0.78 to 1.00)
0.90 (0.69 to 0.98)
0.15 (0.04 to 0.26)
0.43 (0.39 to 0.43)
0.74 (0.70 to 0.75)
0.97 (0.96 to 0.99)
1.7
3.5
5.8
12 months
1
2
3
0.96 (0.79 to 0.99)
0.72 (0.53 to 0.86)
0.24 (0.12 to 0.28)
0.42 (0.38 to 0.43)
0.76 (0.72 to 0.80)
0.99 (0.96 to 1.00)
1.7
3.0
26.4Discussion
Few studies have examined factors at the time of discharge in
order to determine prosthetic use into the future. This is the ﬁrst
study to propose and validate clinical prediction rules for timelinesles at 4 (and 6), 8 and 12 months for the retrospective cohort.
sitive likelihood
ratio
Negative likelihood
ratio
Probability of
prosthetic
non-use (%)
p-value
0 (0.85 to 1.19)
0 (1.40 to 2.09)
0 (1.87 to 4.08)
00 (3.61 to 748)
0 (0.00 to 999+)
0.20 (0.0 to 2.04)
0.06 (0.0 to 0.57)
0.27 (0.07 to 0.65)
0.74 (0.67 to 0.92)
0.97 (0.94 to 1.01)
13
21
29
80
0
0.183
< 0.001
< 0.001
< 0.001
0.223
0 (1.29 to 1.76)
0 (2.31 to 3.98)
0 (0.96 to 34.30)
0.06 (0.00 to 0.55)
0.14 (0.02 to 0.44)
0.87 (0.75 to 1.00)
23
38
50
0.001
< 0.001
0.013
0 (1.28 to 1.74)
5 (1.88 to 4.25)
0 (3.40 to 580.00)
0.10 (0.01 to 0.55)
0.37 (0.17 to 0.66)
0.77 (0.72 to 0.91)
27
41
86
< 0.001
< 0.001
< 0.001
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Figure 2. A survival curve for the proportion of individuals using prostheses for
every month in the year following hospital discharge. Note: The retrospective and
prospective cohorts show similar patterns and rates of prosthetic non-use.
Research 229of 4, 8 and 12 months post-discharge that use statistical optimisa-
tion modelling to select a parsimonious set of variables from the
rehabilitation model of care, which predict increased likelihood of
prosthetic non-use. Previous research has examined univariate
associations with poor outcomes.5 In the present study, a much
wider range of perioperative and demographic factors were
examined and conﬁrmed that a large number of factors are
signiﬁcantly associated with prosthetic non-use. These were
grouped into intrinsic, amputation and functional domains. The
major point of difference from surgical studies12,21,35 was that
causative factors for amputation were not associated with non-use.
The key point of this research, however, was that multivariate
predictive models were used to determine a predictive model of
outcome at four time points. Three clinical prediction rules were
derived and validated, as the results for the 4-month and 6-month
outcomes were identical. These results validate that a subgroup of
early prosthetic non-users exist and can be targeted. The high level
of concordance between retrospective and prospective prosthetic
non-use survival curves demonstrates that there was no substan-
tial change in clinical practice (contamination) during the
validation study. These ﬁndings call for development of a model
of care that optimises outcome for these individuals. Rehabilitation
may focus on optimising transfers, wheelchair mobility, physical
ﬁtness and mental wellbeing rather than prosthetic gait.
The present study found that having a very high number of
comorbidities was signiﬁcantly predictive of prosthetic non-use at
4 months, but not at later time periods. This was an interesting
ﬁnding, as depending on how effectively comorbidities are
managed they may become worse with age.32 However, this
ﬁnding suggests that if prosthetic use can be sustained for the ﬁrst
4 months post-discharge in the presence of this disease burden,
then such systemic conditions may not be highly related to non-
use at a later time. The Charlson Comorbidity Index for bothTable 6
Associated accuracy statistics with 95% conﬁdence intervals for having a combination
Predictors present for
CPR time frames (n)
Sensitivity Speciﬁcity Positive
likelihood ratio
4 (and 6) months
1
2
3
4
5
0.94 (0.61 to 1.0)
0.93 (0.53 to 1.0)
0.50 (0.19 to 0.81)
0.38 (0.12 to 0.44)
0.06 (0 to 0.12)
0.14 (0.09 to 0.15)
0.66 (0.61 to 0.67)
0.86 (0.82 to 0.90)
0.99 (0.96 to 1.0)
0.99 (0.98 to 1.0)
1.09 (0.67 to 1.17)
2.8 (1.36 to 3.03)
3.6 (1.02 to 8.5)
43.9 (2.73 to 999+)
6.9 (0 to 999+)
8 months
1
2
3
0.90 (0.57 to 0.99)
0.70 (0.38 to 0.91)
0.30 (0.09 to 0.35)
0.50 (0.44 to 0.52)
0.82 (0.76 to 0.86)
0.99 (0.96 to 1.0)
1.8 (1.0 to 2.06)
3.9 (1.6 to 6.5)
33.9 (2.1 to 999+)
12 months
1
2
3
0.91 (0.60 to 0.99)
0.46 (0.19 to 0.72)
0.09 (0.005 to 0.14)
0.51 (0.45 to 0.53)
0.84 (0.78 to 0.89)
0.99 (0.97 to 1.0)
1.85 (1.08 to 2.1)
2.8 (0.9 to 6.6)
10.1 (0.19 to 999+)cohorts indicates that non-users were at greater risk of mortality
from comorbid disease than users.32
Validated predictors for prosthetic non-use common to all three
clinical prediction rules were amputation level above transtibial
andmobility aid use. High amputation level has been associated in
the literature with poor prosthetic outcome.11,36 From a functional
perspective, the transtibial prosthesis can be used to facilitate
transfers, while the transfemoral prosthesis is only of functional
assistance when an individual is standing or walking. This may
result in some activities being performed with greater efﬁciency
from a wheelchair or using assistive equipment (eg, individuals
with transfemoral amputation may self-propel a commode rather
than walking to the shower).
Mobility aid use at discharge is more common in individuals
who premorbidly used aids, are frail, deconditioned, have
remaining limb pathology (eg, claudication, osteoarthritis), and
high or multiple limb amputation.37,38 Mobility aids reduce
functionality of gait by limiting capacity to carry objects, however,
use may be necessary to prevent falls.37,38 As mobility aid use is a
predictor of non-use, future research may investigate interven-
tional strategies (eg, mobility aid type, back pack use, prosthetic
componentry) that potentially improve functionality of gait.
At 4months and 8months after discharge, dependencewalking
outdoors on concrete was a signiﬁcant predictor of prosthetic non-
use. Validation of this predictor with early prosthetic non-use is
important, as many locomotor activities require the ability to walk
outdoors on concrete (eg, shopping). Poor prosthetic outcome has
been associated with indoors-only ambulation.11,24
Similar to the literature,5 the present study validated a critical
time frame in which gait retraining needs to occur, because at
12months, a delay of>160 dayswas predictive of non-use.Wound
complications were the commonest delay in both cohorts. Delays
to walking generally result in prolonged wheelchair sitting and
reduced physical activity. Rehabilitation programs may not
provide the exercise intensity to overcome deconditioning or
prevent complications (eg, joint contracture, muscle weakness)
that limit walking capacity. Furthermore, individuals with severe
comorbidities and frailty may adversely or not respond to exercise
intervention.
Although the proportion of non-users of prostheses is
relatively small, these people are difﬁcult to identify; therefore,
these clinical prediction rules will assist clinical decisions during
rehabilitation and primary healthcare planning following dis-
charge. The validated clinical prediction rules for 4 and 8 months
had positive likelihood ratios of 43.9 and 33.9, respectively. These
values are consistent with the interpretation that positive
likelihood ratios of>5 are clinically signiﬁcant.28,39,40 In contrast,
the 12-month clinical prediction rules were statistically signiﬁ-
cant for non-use (p = 0.031) but did not possess the predictive
magnitude of the other clinical prediction rules. To improve theof predictor variables at 4 (and 6), 8 and 12 months for the prospective cohort.
Negative
likelihood ratio
Probability of prosthetic
non-use (%)
Accuracy
(%)
Balanced
accuracy (%)
p
0.43 (0 to 4.40)
0.10 (0 to 0.77)
0.58 (0.21 to 0.99)
0.63 (0.56 to 0.92)
0.95 (0.88 to 1.0)
14
26
33
86
50
24
69
82
92
87
54
80
68
68
52
0.519
0.002
0.013
< 0.001
0.259
0.20 (0.01 to 0.98)
0.37 (0.10 to 0.81)
0.71 (0.65 to 0.95)
24
41
86
56
80
89
70
76
65
0.019
0.001
< 0.001
0.18 (0.009 to 0.9)
0.65 (0.31 to 1.03)
0.92 (0.86 to 1.02)
27
36
67
58
77
84
71
65
54
0.011
0.031
0.095
Roffman et al: Prediction of non-use of prostheses by amputees230clinical utility of the 12-month clinical prediction rules, future
research may incorporate a follow-up assessment at 6-months
post-discharge.
Amputation rate has been reported as being 38 times greater in
Aboriginals who have diabetes.41 In the present study, indigenous
status, geographical isolation from health services and having
diabetes were not predictive of prosthetic non-use. Environmental
conditions in Aboriginal communities, where the terrain is rough,
sociocultural factors and service model strategies such as
telehealth may have contributed to sustained prosthetic use.
The present research had some potential limitations. The
prosthetic-use interview relied on participant recall. Missing data
is a potential issue for retrospective research; however, a strength
of the present study was that it had minimal missing data.
Mortality rate was high within the review period for the
retrospective (16%) and prospective (10%) cohorts; however, the
sensitivity analyses demonstrated that the deceased sub-groups
did not bias clinical prediction rules development or validation.
Although further validation could be undertaken at other
rehabilitation centres, the use of the prospective cohort in the
present study validates the use of these clinical prediction rules by
health professionals.
In conclusion, this is the ﬁrst study to integrate rehabilitation
variables into a parsimonious set of predictors that are signiﬁcant
for prosthetic non-use at 4, 8 and 12 months after discharge, and
validate these clinical prediction rules. The research has validated
that a sub-group of early prosthetic non-users exists, and
highlights a need to separate causative factors for amputation
that impact on surgical outcome, from those related to prosthetic
non-use. These validated clinical prediction rules may guide
clinical reasoning and rehabilitation service development.What is already known on this topic: Long-term functional
use of a prosthesis following discharge from hospital is im-
portant for quality of life for lower limb amputees.
What this study adds: Clinical prediction rules can provide
valid data to help identify people who are at risk of discontinu-
ing use of their prosthesis in the year following discharge from
hospital after lower limb amputation. Different predictors
contribute to these clinical prediction rules, depending on
the time frame considered (4, 8 or 12 months). Amputation
above the transtibial level and use of a mobility aid were
predictors that were common to the clinical prediction rules
for all three time frames.eAddenda: Figures 3, 4 and 5, Tables 1 and 4, and Appendices
1 and 2 can be found online at doi:10.1016/j.jphys.2014.09.003
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